Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
5.38
+0.25 (4.87%)
Sep 17, 2026, 2:07 PM EDT - Market open
Savara Market Cap
Savara has a market cap or net worth of $1.37 billion as of September 17, 2026. Its market cap has increased by 119.15% in one year.
Market Cap
1.37B
Enterprise Value
1.22B
1-Year Change
119.15%
Ranking
Category
Stock Price
$5.38
ChartMarket Cap Chart
Since April 28, 2017, Savara's market cap has increased from $132.70M to $1.37B, an increase of 930.34%. That is a compound annual growth rate of 28.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 1.05B | -14.09% |
| Dec 31, 2025 | 1.23B | 132.85% |
| Dec 31, 2024 | 526.90M | -17.17% |
| Dec 29, 2023 | 636.10M | 259.79% |
| Dec 30, 2022 | 176.80M | 25.21% |
| Dec 31, 2021 | 141.20M | 126.65% |
| Dec 31, 2020 | 62.30M | -66.25% |
| Dec 31, 2019 | 184.60M | -30.58% |
| Dec 31, 2018 | 265.90M | -41.25% |
| Dec 29, 2017 | 452.60M | 241.07% |
| Apr 28, 2017 | 132.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Absci | 1.38B |
| LB Pharmaceuticals | 1.37B |
| ArriVent BioPharma | 1.36B |
| Maze Therapeutics | 1.33B |
| Cullinan Therapeutics | 1.33B |
| ORIC Pharmaceuticals | 1.30B |
| Vor Biopharma | 1.30B |
| Ultragenyx Pharmaceutical | 1.27B |